Selective serotonin reuptake inhibitors in older patients: A tolerability perspective

Drugs and Aging

Volumn 10, Issue 3, 1997, Pages 209-218

  Skerritt, Ursula ^a   Evans, Richard ^a   Montgomery, Stuart A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; CLOMIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; MIANSERIN; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PHENOTHIAZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADRENERGIC ACTIVITY; AGED; AGING; ANTICHOLINERGIC EFFECT; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; DEPRESSION; DRUG CHOICE; DRUG EFFICACY; DRUG ELIMINATION; DRUG OVERDOSE; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; HYPONATREMIA; META ANALYSIS; NAUSEA; NERVOUSNESS; OBESITY; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SEDATION; SEROTONIN SYNDROME; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; SYMPTOM; VERTIGO; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 8044254626     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199710030-00005     Document Type: Review

References (74)

1. Blazer D. The diagnosis of depression in the elderly. J Am Geriatr Soc 1980; 28: 52-8
2. Lindesay J, Briggs K, Murphy E. The Guy's/Age Concern survey: prevalence rates of cognitive impairment, depression and anxiety in an urban elderly community. Br J Psychiatry 1989; 155: 317-29
3. Gurland B, Copeland J, Kurlansky J, et al. The mind and mood of ageing. London/New York: Croom Helm, 1983
4. Murphy E. The prognosis of depression in old age. Br J Psychiatry 1983; 141: 111-9
5. Conwell Y, Brent D. Suicide and ageing: I. Patterns of psychiatric diagnosis. Int Psychogeriatr 1995; 7: 149-64
6. Fiehel JH, Springer CJ. Depression and failure to resume social activities after stroke. Arch Phys Med Rehabil 1982; 63: 276-8
7. Silverstone PH. Depression increases mortality and morbidity in acute life-threatening medical illness. J Psychosom Res 1990; 34: 651-7
8. Bayer AJ, Pathy MS. Identification of depression in geriatric medical patients. In: Ghose K, editor. Antidepressants for elderly people. London: Chapman and Hall, 1989: 13-25
9. Montgomery SA. Treatment of depression in old age. In: Wheatley D, editor. Psychopharmacology of old age. Oxford: Oxford University Press, 1982: 165-72
10. Georgotas A, McCue RE, Cooper TB, et al. Factors affecting the delay of antidepressant effect in responders to nortripty-line and phenelzine. Psychiatry Res 1989; 28: 1-9
11. Cole MG. The prognosis of depression in the elderly. Can Med Assoc J 1990; 142: 633-9
12. Baldwin RC, Jolley DJ. The prognosis of depression in old age. Br J Psychiatry 1986; 149: 574-83
13. Montgomery SA, Lack SJ. Pharmacokinetic principles in the treatment of depression in the elderly. In: Stefanis CN, Rabavilas AD, Soldatos CR, editors. Psychiatry: a world perspective. Amsterdam: Elsevier, 1990: 40-5
14. Johnson DAW. Depression: treatment compliance in general practice. Acta Psychiatr Scand 1981; 63 Suppl. 290: 447-53
15. Moskowitz H, Burns MM. Cognitive performance in geriatric subjects after acute treatment with antidepressants. Neuropsychobiology 1986; 15 Suppl. I: 38-43
16. Nolan L, O'Malley K. Adverse effects of antidepressants in the elderly. Drugs Aging 1992; 2: 450-8
17. Ray WA. Psychotropic drugs and injuries among the elderly: a review. J Clin Psychopharmacol 1992; 12: 386-96
18. Campbell AJ. Drug treatment as a cause of falls in old age: a review of offending agents. Drugs Aging 1991; 1: 289-302
19. Salzman C. Pharmacologic treatment of depression in the elderly. J Clin Psychiatry 1993; 54 Suppl. 2: 23-8
20. Montgomery SA. New psychotropic drugs for the acute treatment of depressive episodes. In: Costa E, Silva JA, Nadelson CC, editors. International review of psychiatry. Washington, DC: American Psychiatric Press, 1993: 139-60
21. Andersen J, Bech P, Benjaminsen S, et al. Citalopram: clinical efficacy profile in comparison with clomipramine. A controlled multicentre study. Psychopharmacology 1986; 90: 131-8
22. Danish University Antidepressant Group. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerability but weaker antidepressant effect than clomipramine in a controlled multicentre study. J Affect Disord 1990; 18: 289-99
23. Anderson IM, Tomensen BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclicantidepressants: a meta-analysis. BMJ 1995; 310: 1433-8
24. Montgomery SA, Henry J, Mcdonald G, et al. Selective serotonin reuptake inhibitors: metaanalysis of discontinuation rates. Int Clin Psychopharmacol 1994; 9: 47-53
25. Katona CLE. Treating depression in older people. In: Feighner JP, Boyer WF, editors. Selective serotonin re-uptake inhibitors: advances in basic research and clinical practice. Chichester: John Wiley, 1996: 179-204
26. Wakelin JS. Fluvoxamine in the treatment of the older depressed patient: double blind placebo controlled data. Int Clin Psychopharmacol 1986; I: 221-30
27. Rahman MK, Akhtar MJ, Savla NC, et al. A double-blind, randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients. Br J Clin Pract 1991; 45: 255-8
28. Phanjoo AL, Wonnacott S, Hodgson A. Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people. Acta Psychiatr Scand 1991; 83: 476-9
29. Tollefson GD, Holman SJL. Analysis of the Hamilton Depression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression. Int Clin Psychopharmacol 1993; 8: 253-9
30. Feighner JP, Cohn JB. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiatry 1985; 46: 20-5
31. Altamura AC, Percudani M, Guercetti G, et al. Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitriptyline. Int Clin Psychopharmacol 1989; 4: 103-6
32. Falk WE, Rosenbaum JE, Otto MW, et al. Fluoxetine versus trazodone in depressed geriatric patients. J Geriatr Psychiatry Neurol 1989; 2: 208-14
33. Dunner DL, Cohn JB, Walshe T, et al. Two combined multicentre double-blind studies of paroxetine and doxepin in geriatric patients with major depression. J Clin Psychiatry 1992; 53: 57-60
34. Guillibert E, Pelicier Y, Archambault JL, et al. A double-blind, multi-centre study of paroxetine v clomipramine in depressed elderly patients. Acta Psychiatr Scand 1989; 80 Suppl. 350: 132-4
35. Hutchinson DR, Tong S, Moon CAL, et al. A double-blind study in general practice to compare the efficacy and tolerability of paroxetine and amitriptyline in depressed elderly patients. Br J Clin Res 1991; 2: 43-7
36. Dorman T. Sleep and paroxetine: a comparison with mianserin in elderly depressed patients. J Clin Psychiatry 1992; 53 Suppl.: 53-8
37. Schone W, Ludwig M. Adouble-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression. J Clin Psychopharmacol 1993; 13 Suppl. 2: 34-9
38. Dunbar GC. Paroxetine in the elderly: a comparative metaanalysis against standard antidepressant pharmacotherapy. Pharmacology 1995; 51: 127-44
39. Cohn CK, Shrivastava R, Mendel SJ, et al. Double blind multicentre comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry 1990; 51 Suppl. 8: 28-33
40. Nyth AL, Gottfries CG. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders: a Nordic multicentre study. Br J Psychiatry 1990; 157: 894-901
41. Nyth A, Gottfries CG, Lyby K, et al. A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatr Scand 1989; 86: 138-45
42. Montgomery SA. The efficacy of fluoxetine as an antidepressant in the short and long term. Int Clin Psychopharmacol 1989; 4 Suppl. 1: 113-9
43. Kerr JS, Sherwood N, Hindmarch I. The comparative psychopharmacology of 5-HT re-uptake inhibitors. Hum Psychopharm 1991; 6: 313-7
44. Price J, Waller P, Wood S, et al. Safety of fluoxetine: comparison with fluvoxamine. Pharmacoepidemiol Drug Saf 1992; 1: 111-7
45. Wagner W, Plekkenpol B, Gray TE, et al. Review of fluvoxamine safety database. Drugs 1992; 43 Suppl. 2: 48-54
46. Wakelin JS. The role of serotonin in depression and suicide: do serotonin reuptake inhibitors provide a key? Adv Biol Psychiatry 1988; 17: 70-83
47. Montgomery SA. The advantages of paroxetine in different subgroups of depression. Int Clin Psychopharmacol 1992; 6 Suppl. 4: 91-100
48. Herman JB, Brotman AW, Pollack MH, et al. Fluoxetine-induced sexual dysfunction. J Clin Psychiatry 1990; 51: 25-7
49. Cooper GL. The safety of fluoxetine: an update. Br J Psychiatry 1988; 153 Suppl. 3: 77-86
50. Hindmarch I. Antidepressants: the implications of the cognitive and psychomotor effects in the elderly. Int Clin Psychopharmacol 1990; 5 Suppl. 3: 57-60
51. Moro F, Scapagnini U, Scaletta S, et al. Serotonin nerve endings and regulation of pupillary diameter. Ann Ophthalmol 1981; 13: 487-90
52. Roose SP, Glassman AH, Giardina EG, et al. Tricyclic antidepressants in depressed patients with cardiac conduction disease. Arch Gen Psychiatry 1987; 44: 273-5
53. Amin MM, Ananth JV, Coleman BS, et al. Fluvoxamine: antidepressant effect confirmed in a placebo-controlled international study. Clin Neuropharmacol 1984; 7 Suppl. I: 317-8
54. Guy S, Silke B. The electrocardiogram as a tool for therapeutic monitoring: a critical analysis. J Clin Psychiatry 1990; 51 Suppl. 8: 37-9
55. Evans ME, Lye M. Depression in the elderly physically ill: an age study of treatment with the 5HT reuptake inhibitor fluoxetine. J Clin Exp Gerontol 1992; 14: 297-307
56. Fisch C. Effect of fluoxetine on the electrocardiogram. J Clin Psychiatry 1985; 46 Suppl. 3: 42-4
57. Ellison JM, Milofsky JE, Ely E. Fluoxetine induced bradycardia and syncope in two patients. J Clin Psychiatry 1990; 51: 385-6
58. Buff D, Brenner R, Kirtane SS, et al. Dysthymia associated with fluoxetine treatment in an elderly patient with cardiac disease. J Clin Psychiat 1991; 52: 174-6
59. Spier SA, Frontera MA. Unexpected deaths in depressed medical inpatients treated with fluoxetine. J Clin Psychiatry 1991; 52: 377-82
60. Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ 1995; 310: 221-4
61. Montgomery SA, Dunner DL, Dunbar GC. Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropsychopharmacol 1995; 5: 5-13
62. Song F, Freemantle N, Sheldon TA, et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ 1993; 306: 683-7
63. Hebenstreit FG, Fellerer K, Zochling R, et al. A pharmacokinetic dose titration study in adult and elderly depressed patients. Acta Psychiatr Scand 1989; 80 Suppl. 350: 81-4
64. Montgomery SA, Pedersen V, Tangjhoj P, et al. The optimal dosing regime for citalopram: a meta-analysis of nine placebo-controlled studies. Int Clin Psychopharmacol 1994; 9 Suppl. 1: 35-40
65. Jenner PB. Paroxetine: an overview of dosage, tolerability, and safety. Int Clin Psychopharmacol 1992; 6 Suppl. 4: 69-80
66. Fredericson-Overo K, Toft B, Christopherson L, et al. Kinetics of citalopram in elderly patients. Psychopharmacology (Berl) 1985; 86: 253-7
67. Lemberger L, Bergstrom RF, Wolen RL, et al. Fluoxetine: clinical pharmacology and physiologic disposition. J Clin Psychiatry 1985; 46: 14-9
68. Murdoch D, McTavish D. Sertraline: a review of its pharmacodynamic and pharmacokinetic properties, therapeutic potential in depressive illness, and prospective role in the treatment of obsessive-compulsive disorder. Drugs 1992; 44: 604-24
69. Benfield P, Ward A. Fluvoxamine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 1986; 32: 313-34
70. Schenker S, Bergstrom RF, Wolen RL, et al. Fluoxetine disposition and elimination in cirrhosis. Clin Pharmacol Ther 1988; 44: 353-9
71. Baumann P. Clinical pharmacokinetics of citalopram and other selective serotonergic reuptake inhibitors. Int Clin Psychopharmacol 1992; 6 Suppl. 5: 13-20
72. Beasley CM, Masica DN, Heiligenstein JH, et al. Possible monoamine oxidase inhibitor serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings. J Clin Psychopharmacol 1993; 13: 312-20
73. Graber MA, Hoehns TB, Perry PJ. Sertraline-phenelzine drug interaction: a serotonin syndrome reaction. Ann Pharmacother 1994; 28: 732-5
74. Committee on Safety of Medicines. Antidepressant-induced hyponatraemia. Curr Prob Pharmacovigilance 1994; 20: 5-6